http://www.sciencedaily.com/releases/2012/04/120408150618.htm
An encouraging piece showing where things might go... but not tomorrow. All we have to do is fix a few switches it seems, sounds simple enough....
"In a paper published April 8 in Nature, the scientists say that controlling the activity of two molecules - which work together to allow more or less glucose production - could potentially offer a new way to lower blood sugar to treat insulin-resistant type II diabetes. They showed, through an experimental technique, that this was possible in diabetic mice.
"If you control these switches, you can control the production of glucose, which is really at the heart of the problem of type 2 diabetes," says Professor Marc Montminy, head of Salk's Clayton Foundation Laboratories for Peptide Biology.
An encouraging piece showing where things might go... but not tomorrow. All we have to do is fix a few switches it seems, sounds simple enough....
"In a paper published April 8 in Nature, the scientists say that controlling the activity of two molecules - which work together to allow more or less glucose production - could potentially offer a new way to lower blood sugar to treat insulin-resistant type II diabetes. They showed, through an experimental technique, that this was possible in diabetic mice.
"If you control these switches, you can control the production of glucose, which is really at the heart of the problem of type 2 diabetes," says Professor Marc Montminy, head of Salk's Clayton Foundation Laboratories for Peptide Biology.
